Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate Pythia T Nieuwkerk, Petra J Hajenius, M.D., Fulco Van der Veen, M.D., Ph.D., Willem M Ankum, M.D., Ph.D., Wouter Wijker, Ph.D., Patrick M.M Bossuyt, Ph.D. Fertility and Sterility Volume 70, Issue 3, Pages 518-522 (September 1998) DOI: 10.1016/S0015-0282(98)00213-1
FIGURE 1 Patient preferences for systemic methotrexate therapy relative to laparoscopic salpingostomy. • = patients treated with systemic methotrexate; ∗ = patients treated by salpingostomy; □ = control patients. Vertical dotted line at 80% = tubal patency rate after salpingostomy. Fertility and Sterility 1998 70, 518-522DOI: (10.1016/S0015-0282(98)00213-1)